Login / Signup

Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG.

Merve Yoldas ÇelikHavva YazıcıFehime ErdemAyse Yuksel YanboluAyca AykutAsude DurmazSelcan ZeybekEbru CandaSema Kalkan UçarMahmut Coker
Published in: Journal of pediatric endocrinology & metabolism : JPEM (2023)
This study contributes to the literature by sharing our ultra-rare DPM1-CDG case with less than 20 cases in the literature and expanding the clinical and molecular characteristics of other CDG patients. Hyperinsulinemic hypoglycemia, short stature, hypothyroidism, growth hormone deficiency, hypogammaglobulinemia, pericardial effusion, elevated CK, congenital myasthenia, and anorectal malformation were unique findings that were observed. Cerebello-ocular findings accompanying multi-organ involvement were an essential clue for a possible CDG.
Keyphrases
  • growth hormone
  • systematic review
  • end stage renal disease
  • type diabetes
  • newly diagnosed
  • ejection fraction
  • social media
  • skeletal muscle
  • patient reported outcomes
  • adipose tissue
  • insulin resistance